|
SPPL2A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.12390097228854E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.95234972422531E-12 |
| Normal-vs-Stage2 |
4.39010000019557E-07 |
| Normal-vs-Stage3 |
9.984800E-03 |
| Normal-vs-Stage4 |
6.15669999999291E-05 |
| Stage1-vs-Stage2 |
7.551200E-01 |
| Stage1-vs-Stage3 |
2.218400E-01 |
| Stage1-vs-Stage4 |
7.480600E-01 |
| Stage2-vs-Stage3 |
3.777400E-01 |
| Stage2-vs-Stage4 |
9.233400E-01 |
| Stage3-vs-Stage4 |
4.857600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62536650805123E-12 |
| Normal-vs-AfricanAmerican |
2.235900E-04 |
| Normal-vs-Asian |
9.909600E-01 |
| Caucasian-vs-AfricanAmerican |
2.534500E-02 |
| Caucasian-vs-Asian |
3.243200E-01 |
| AfricanAmerican-vs-Asian |
5.118800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62503344114384E-12 |
| Normal-vs-Female |
9.448700E-04 |
| Male-vs-Female |
4.432200E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.03109999999951E-05 |
| Normal-vs-Extreme_Weight |
1.62458935193399E-12 |
| Normal-vs-Obese |
1.02999997420028E-09 |
| Normal-vs-Extreme_Obese |
1.218960E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.920000E-02 |
| Normal_Weight-vs-Obese |
7.541600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.231000E-01 |
| Extreme_Weight-vs-Obese |
2.611800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.221400E-01 |
| Obese-vs-Extreme_Obese |
6.570200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.999200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.51640042137069E-10 |
| Normal-vs-Age(61-80Yrs) |
2.29705143794945E-13 |
| Normal-vs-Age(81-100Yrs) |
1.0177999998362E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.000200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.706160E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.636200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.635800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.143400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.678000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
1.589570E-04 |
| Normal-VS-KIRP CIMP |
2.263000E-03 |
| Normal-VS-Unclassified PRCC |
1.377080E-04 |
| Type1 PRCC-VS-Type2 PRCC |
6.810100E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.038010E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.141800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.893000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.286400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.604400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.96349999989931E-07 |
| Normal-vs-N1 |
1.834260E-02 |
| Normal-vs-N2 |
1.302570E-03 |
| N0-vs-N1 |
6.328600E-01 |
| N0-vs-N2 |
6.602800E-01 |
| N1-vs-N2 |
6.109600E-01 |
|
|
